Atlas Trials

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Clinical trial NCT06108830 · RECRUITING

Trial details

NCT number
NCT06108830
Sponsor
Tianjin Medical University General Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Sleep Disturbance
Start date
2023-12-01
Primary completion
2024-11-30
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.